Safety Information

Description Publish Date LINKS
Important safety information on Abacavir: Hypersensitivity reaction - educational slide deck 15/02/2024
Important safety information on Dolutegravir in Cameroon
10/06/2018

Important safety information on Non-steroidal anti-inflammatory drugs (NSAlDs) in Cameroon 11/06/2021
Important safety information on Cephalosporins in Cameroon (Safety Notification_Cephalosporins and risk of seizure) 01/03/2023

Important safety information on Cephalosporins in Cameroon (Safety Notification_Cephalosporins and risk of neurotoxicity)

07/03/2023

Important safety information on Amoxicillin / Amoxicillin and clavulanic acid containing products in Cameroon

09/09/2023
Important safety information on Paroxetine in Cameroon (Safety Notification_EMA communication issued relating to Paroxetine label update) 27-10-2023
Important safety information on Cefuroxime sodium in Cameroon (Safety Notification_Cefuroxime Class 4 Defect MHRA) 30-10-2023
Important safety information on Topical Corticosteroids containing products in Cameroon 15-11-2023